Majority of US Consumers Intending to Purchase Wearables Are Willing to Pay More For Devices With Health and Medical Features
11 Aug 2022
Collaborate
Parks Associates' Connected Health Summit features Jasper Health, Omron, Garmin, Becklar, and more speaking about new opportunities for health monitoring
DALLAS, Aug. 11, 2022 /PRNewswire/ -- Parks Associates will host the Connected Health Summit virtual session "New Era of Emergency Response and Remote Patient Monitoring" on Tuesday, August 30, 11 AM CT US, to discuss new opportunities for health monitoring, including cardiac conditions, sleep disorders, and safety monitoring for all ages. Event sponsors include ADT Medical Alert, Alarm.com, EarlySense, Johnson Controls, Rapid Response Monitoring, Becklar, and Independa.
Continue Reading
Preview
Source: PRNewswire
Connected Health Summit
Parks Associates finds that 28% of US internet households intend to purchase a wearable within the next six months, and health and medical features are very popular with this cohort. Approximately 95% are willing to pay more for a wearables model if it has advanced health features, including 66% who would pay more for a device that accurately measures blood pressure and can share that information with their doctor.
"Wearables intenders are most likely to pay more for medical-grade vital sign detection, particularly blood pressure, arrhythmia, and blood oxygen levels. There is also high interest in fall detection features," said Kristen Hanich, Director, Research, Parks Associates. "Likely buyers ages 25-44 are more likely than those in other age groups to be willing to pay more for health-related features, even for fall detection. That said, fall detection is the #1 feature for consumers ages 65 and older."
"New Era of Emergency Response and Remote Patient Monitoring" features interactive panel sessions, along with a keynote presentation from Adam Pellegrini, CEO and Co-Founder,
Jasper Health. The panels "Remote Patient Monitoring: Solving Health Issues in Real Time" and "Wearables for Health: Tech is the New Normal" analyzes new programs developed around remote patient monitoring and opportunities emerging from the growing number of use cases for wearables.
Speakers:
Dr. Waqaas Al-Siddiq, CEO,
Biotricity
Morgan Hertel, VP, Technology and Innovation,
Rapid Response Monitoring
Amar Kendale, President,
Dan McCaffrey, VP, Digital Health and Software,
Tejaswini Mishra, PhD, Research Scientist, Genetics,
Stanford School of Medicine
Shyamal Patel, PhD, Head of Science,
OURA
Jörn Watzke, Senior Director Garmin Health,
Brock Winzeler, President of Freeus, Becklar Workforce Safety, and Becklar Connected Wellness,
Becklar
Parks Associates will host additional virtual Connected Health Summit sessions in 2022:
August 31: Successful Strategies for Engaging Consumers
October 6: Seniors and Caretakers: Living Independently
For additional connected health research, download the whitepaper Health at Home: New Era of Healthcare from Parks Associates, produced in partnership with EarlySense®.
To join the conversation, visit www.connectedhealthsummit.com. To request data or an interview, contact Rosey Sera, [email protected], 972-996-0233.
About Connected Health Summit
Connected Health Summit: Consumer Engagement and Innovation is a virtual executive conference focused on the impact of connected devices and IoT healthcare solutions on consumers at home.
Connected Health Summit provides insights on new business models, IoT technologies, consumer behaviors, and deployments relevant to consumer healthcare solutions. The conference addresses opportunities for new solutions, including smart home platforms, on-demand services, voice assistants, and wearables, to empower consumers, caregivers, and providers and to meet the growing demand for services in independent living, chronic care management, remote access to care, and wellness and fitness. www.connectedhealthsummit.com
Contact:
Rosey Sera
Parks Associates
972.996.0233
[email protected]
SOURCE Parks Associates
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.